Protection from obesity-induced insulin resistance in mice lacking TNF-α function
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitus. The molecular basis of this common syndrome, however, is poorly understood. It has been suggested that tumour necrosis factor (TNF)-alpha is a candidate mediator of insulin resistance in obesity, as it is overexpressed in the adipose tissues of rodents and humans and it blocks the action of insulin in cultured cells and whole animals. To investigate the role of TNF-alpha in obesity and insulin resistance, we have generated obese mice with a targeted null mutation in the gene encoding TNF-alpha and those encoding the two receptors for TNF-alpha. The absence of TNF-alpha resulted in significantly improved insulin sensitivity in both diet-induced obesity and that resulting for the ob/ob model of obesity. The TNFalpha-deficient obese mice had lower levels of circulating free fatty acids, and were protected from the obesity-related reduction in the insulin receptor signalling in muscle and fat tissues. These results indicate that TNF-alpha is an important mediator of insulin resistance in obesity through its effects on several important sites of insulin action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a number of animal studies where inflammatory pathways are genetically down regulated demonstrate that preventing obesity induced inflammation can prevent the development of insulin resistance [159,160].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [159]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“gif" NDATA ITEM> ]> Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitu”
BackgroundWhite, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
The Mouse in Biomedical Research
(1983) · Elsevier eBooks · doi:10.1016/c2013-0-10677-0 · Cited by 1,012
Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 932 · cited 1×
“To test the importance of the TNFα-activated pathway of insulin resistance in the most severe, genetic model of obesity, we generated genetically obese ( ob/ob ) mice with targeted mutations in both p55 and p75 TNF receptors, effectively abolishing the signalling and function of TNF-α in these animal”
BackgroundHotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Research works printed but not linked: 1
- Olefsky, J. M. & Molina, J. M. in Diabetes Mellitus (eds Rifkin, H. & Porte, D. J.) 121–153 (Elsevier, New York, (1990)).
Cited by
Items 901–1,000 of 1,010
Xu, Q., Huang, L. F., Liu, J., Ma, L., Chen, T., Chen, J., Peng, F., Cao, D., Yang, Z., Qiu, N., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.006 · Cited by 64
Hernández, R., Teruel, T., de Álvaro, C., & Lorenzo, M. (2004) · Diabetologia · doi:10.1007/s00125-004-1503-7 · Cited by 68
“Tumour necrosis factor-α has been proposed as a link between adiposity and the development of insulin resistance, since most Type 2 diabetic patients are obese and have increased TNF-α expression in fat cells, and obese mice lacking TNF-α function are protected from developing insulin resistance [1, 2, 3].”
BackgroundIwata, T., Sato, S., Jimenez, J., McGowan, M. H., Moroni, M., Dey, A., Ibaraki, N., Reddy, V. N., & Carper, D. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7993 · Cited by 70
Wolf, D., Jehle, F., Michel, N. A., Bukosza, É. N., Rivera, J., Chen, Y., Hoppe, N., Dufner, B., Rodríguez, A. O., Colberg, C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.008055 · Cited by 67
Jin, D., Sun, J., Huang, J., He, Y., An, Y., Yu, X., & Yang, Z. (2014) · Cytokine · doi:10.1016/j.cyto.2014.06.005 · Cited by 63
Montecucco, F., Steffens, S., & Mach, F. (2008) · Mediators of Inflammation · doi:10.1155/2008/767623 · Cited by 78
Bullo, M., Garcia-Lorda, P., & Salas-Salvado, J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460325 · Cited by 63
Tumour necrosis factor, a key role in obesity?
Bulló-Bonet, M., García-Lorda, P., López-Soriano, F. J., Argilés, J. M., & Salas-Salvadó, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00540-2 · Cited by 65
Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease
Benjafield, A., Wang, X. L., & Morris, B. J. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000168 · Cited by 66
“In this regard, TNF-α decreases autophosphorylation of the insulin receptor [36] and phosphorylation of insulin receptor substrate 1 that then inhibits insulin receptor tyrosine kinase to attenuate insulin receptor signalling [37], decreasing GLUT-4 transporter in muscle cells [36], increasing leptin [38], circulating…”
BackgroundPolakof, S., Diaz-Rubio, M. E., Dardevet, D. P., Martin, J.-F., Pujos‐Guillot, E., Scalbert, A., Sébédio, J., Mazur, A., & Comte, B. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.05.008 · Cited by 64
TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis
Jiang, Y., Zhang, Q., Soderland, C., & Steinle, J. J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.003 · Cited by 62
Metabolism and secretory function of white adipose tissue: effect of dietary fat
do Nascimento, C. M. O., Ribeiro, E. B., & Oyama, L. M. (2009) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652009000300010 · Cited by 82
Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects
Mintoff, D., Benhadou, F., Pace, N. P., & Frew, J. W. (2021) · International Journal of Dermatology · doi:10.1111/ijd.15910 · Cited by 67
The role of S100B in the interaction between adipocytes and macrophages
Fujiya, A., Nagasaki, H., Seino, Y., Okawa, T., Kato, J., Fukami, A., Himeno, T., Uenishi, E., Tsunekawa, S., Kamiya, H., et al. (2013) · Obesity · doi:10.1002/oby.20532 · Cited by 67
Chen, Y., Wang, Y., Zhang, J., Sun, C., & Lopez, A. (2011) · ISRN Endocrinology · doi:10.5402/2011/519371 · Cited by 56
Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats
Shan, C. Y., Yang, J. H., Kong, Y., Wang, X. Y., Zheng, M. Y., Xu, Y. G., Wang, Y., Ren, H. Z., Chang, B. C., & Chen, L. M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0184 · Cited by 58
“The definitive proof of such a connection between inflammatory mediators and insulin resistance in obesity and T2DM came from genetic studies that interfered with inflammatory mediators and demonstrated beneficial effects of this interference on insulin action (Uysal et al. 1997).”
BackgroundMacrophage heterogeneity and energy metabolism
Verdeguer, F., & Aouadi, M. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.043 · Cited by 65
Kern, P. A., Dicker-Brown, A., Said, S. T., Kennedy, R. H., & Fonseca, V. A. (2002) · Metabolism · doi:10.1053/meta.2002.28088 · Cited by 61
An extensive phenotypic characterization of the hTNFα transgenic mice
Hayward, M. D., Jones, B. K., Saparov, A., Hain, H. S., Trillat, A.-C., Bunzel, M. M., Corona, A., Li-Wang, B., Strenkowski, B., Giordano, C., et al. (2007) · BMC Physiology · doi:10.1186/1472-6793-7-13 · Cited by 56
Neferine enhances insulin sensitivity in insulin resistant rats
Pan, Y., Cai, B., Wang, K., Wang, S., Zhou, S., Yu, X.-C., Xu, B., & Chen, L. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.04.008 · Cited by 62
“Obese mice lackng either TNF- gene or its receptors showed protection against eveloping insulin resistance (Uysal et al., 1997, 1998).”
BackgroundAvailable, N. (1998) · Diabetologia · doi:10.1007/s001250051000 · Cited by 67
“Targeted mutations in the genes of TNF-a and the two TNF-receptors resulted in an improved insulin sensitivity in animal models of obesity [5, 6].”
BackgroundLinks between Childhood Obesity, High-Fat Diet, and Central Precocious Puberty
Calcaterra, V., Magenes, V. C., Hruby, C., Siccardo, F., Mari, A., Cordaro, E., Fabiano, V., & Zuccotti, G. (2023) · Children · doi:10.3390/children10020241 · Cited by 62
Association of Obesity With Inflammation and Pain After Total Hip Arthroplasty
Motaghedi, R., Bae, J. J., Memtsoudis, S. G., Kim, D. H., Beathe, J. C., Paroli, L., YaDeau, J. T., Gordon, M. A., Maalouf, D. B., Lin, Y., et al. (2013) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-013-3282-2 · Cited by 65
Influence of Physical Activity and Nutrition on Obesity‐Related Immune Function
Huang, C., Zourdos, M. C., Jo, E., & Ormsbee, M. J. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/752071 · Cited by 64
“Therefore, the purpose of this review is to comprehensively evaluate the impact of lifestyle factors, in particular psychological stress, physical activity, and nutrition, on obesity-related immune function with special focus on inflammation.”
BackgroundBharti, P., Katagiri, S., Nitta, H., Nagasawa, T., Kobayashi, H., Takeuchi, Y., Izumiyama, H., UCHIMURA, I., Inoue, S., & Izumi, Y. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.11.005 · Cited by 70
Different effects of statins on induction of diabetes mellitus: an experimental study
Zhao, S., & Wang, Z. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s87979 · Cited by 63
Değirmenci, İ., Özbayer, C., Kebapçı, M. N., Kurt, H., Çolak, E., & Güneş, H. V. (2019) · Inflammation Research · doi:10.1007/s00011-019-01263-7 · Cited by 63
Stress, the Endoplasmic Reticulum, and Insulin Resistance
TSIOTRA, P. C., & TSIGOS, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.007 · Cited by 56
Kato, H., Ohue, M., Kato, K., Nomura, A., Toyosawa, K., Furutani, Y., Kimura, S., & Kadowaki, T. (2001) · Diabetes · doi:10.2337/diabetes.50.1.113 · Cited by 63
Obesity and asthma: cause for concern
Shore, S. A. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.01.004 · Cited by 69
“In support of this hypothesis, obese mice genetically deficient in TNF-a do not develop other obesity-related diseases such as insulin resistance, whereas wild-type obese mice do [48].”
BackgroundIdentification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia
Geurts, J. M. W. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.14.2067 · Cited by 61
Sao, R., & Aronow, W. S. (2018) · Archives of Medical Science · doi:10.5114/aoms.2017.68821 · Cited by 56
Role of Flavonoids in the Interactions among Obesity, Inflammation, and Autophagy
García‐Barrado, M. J., Osma, M. D. C. I., García, E. P., Carrero, S., Blanco, E. J., Carretero‐Hernández, M., & Carretero, J. (2020) · Pharmaceuticals · doi:10.3390/ph13110342 · Cited by 64
Seo, J. B., Noh, M. J., Yoo, E. J., Park, S. Y., Park, J., Lee, I. K., Park, S. D., & Kim, J. B. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0028 · Cited by 64
Kern, P. A., Fishman, R. B., Song, W., Brown, A.-D., & Fonseca, V. A. (2002) · Toxicology · doi:10.1016/s0300-483x(01)00564-9 · Cited by 63
“, 1995) and high fat feeding (Uysal et al., 1997), which may explain some of the insulin resistance of obese rodents and humans (Kern, 1997).”
BackgroundMast cells squeeze the heart and stretch the gird: Their role in atherosclerosis and obesity
Theoharides, T. C., Sismanopoulos, N., Delivanis, D.-A., Zhang, B., Hatziagelaki, E. E., & Kalogeromitros, D. C. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.005 · Cited by 59
Zelenko, Z., & Gallagher, E. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.008 · Cited by 55
Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs
Aggarwal, D., Fernández, M. L., & Soliman, G. A. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.017 · Cited by 65
“Tumor necrosis factor-a is considered a candidate mediator of IR in obesity, is overexpressed in adipose tissue [52], and blocks the action of insulin in cultured cells as well as in humans [53].”
BackgroundRosenzweig, T., Braiman, L., Bak, A., Alt, A., Kuroki, T., & Sampson, S. R. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1921 · Cited by 68
Fawcett, R. L., Waechter, A. S., Williams, L. B., Zhang, P., Louie, R., Jones, R., Inman, M., Huse, J., & Considine, R. V. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6359 · Cited by 58
Peroxisome proliferator-activated receptors in endothelial cell biology
Plutzky, J. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200110000-00006 · Cited by 60
Adipokines as Clinically Relevant Therapeutic Targets in Obesity
Würfel, M., Blüher, M., Stümvoll, M., Ebert, T., Kovacs, P. L., Tönjes, A., & Breitfeld, J. (2023) · Biomedicines · doi:10.3390/biomedicines11051427 · Cited by 60
“Furthermore, obese mice with a genetic mutation leading to lacking TNF-α presented significantly improved IS and lower circulating free fatty acids [166].”
BackgroundChronic Exposure to TNFα Impairs Secretion of Glucagon-Like Peptide-1
Gagnon, J., Sauvé, M., Zhao, W., Stacey, H. M., Wiber, S. C., Bolz, S.-S., & Brubaker, P. L. (2015) · Endocrinology · doi:10.1210/en.2015-1361 · Cited by 53
Shimizu, M., Tanaka, T., & Moriwaki, H. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0336-6 · Cited by 59
EFFECTS OF FENOFIBRATE AND XUEZHIKANG ON HIGH‐FAT DIET‐INDUCED NON‐ALCOHOLIC FATTY LIVER DISEASE
Hong, X. Z., Li, L. D., & Wu, L. M. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04547.x · Cited by 54
“Tumour necrosis factor-a inhibits the propagation of insulin receptor-initiated signals in hepatocytes and is known to promote insulin resistance and steatohepatitis in ob/ob mice and in NAFLD patients.(33,34) The present study first demonstrated that xuezhikang inhibited TNF-a mRNA expression, improved insulin resist…”
BackgroundGarcia, F. A. D. O., Rebouças, J. F., Balbino, T. Q., da Silva, T. G., de Carvalho-Júnior, C. H. R., Cerqueira, G. S., Brito, G. A. D. C., & Viana, G. S. D. B. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0080-5 · Cited by 60
“Others indicated that pro-inflammatory cytokines, as IL-6 and TNF-alpha, affected the secretion and efficiency of insulin [13-17].”
BackgroundMarathe, C., Bradley, M. N., Hong, C., Chao, L., Wilpitz, D., Salazar, J., & Tontonoz, P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800189-jlr200 · Cited by 56
Good, M., Newell, F. M., Haupt, L. M., Whitehead, J. P., Hutley, L. J., & Prins, J. B. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.003 · Cited by 57
Surgical removal of visceral adipose tissue: Effects on insulin action
Gabriely, I., & Barzilai, N. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0064-3 · Cited by 65
van Tilburg, J. H. O., Sandkuijl, L. A., Strengman, E., van Someren, H., Rigters-Aris, C. A. E., Pearson, P. L., van Haeften, T. W., & Wijmenga, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021252 · Cited by 58
Heijmans, B. T., Westendorp, R. G. J., Droog, S., Kluft, C., Knook, D. L., & Slagboom, P. E. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363859 · Cited by 61
Gao, H., Luo, Z., Jin, Z., Ji, Y., & Ying, W. (2021) · Cells · doi:10.3390/cells10092451 · Cited by 59
Metabolic Syndrome: The Constellation of Co-morbidities, A Global Threat
Madan, K., Paliwal, S., Sharma, S. K., Kesar, S., Chauhan, N., & Madan, M. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230309144825 · Cited by 65
Regulation of obesity and insulin resistance by hypoxia-inducible factors
Kim, J., Ban, J.-J., Ruthenborg, R., & Cho, K. (2014) · Hypoxia · doi:10.2147/hp.s68771 · Cited by 53
Zang, Y., Igarashi, K., & Yu, C. (2015) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.955453 · Cited by 59
Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 61
“In contrast, animals with disrupted TNF signaling are protected from obesity-induced insulin resistance [211, 213].”
BackgroundHepatic TRAF2 Regulates Glucose Metabolism Through Enhancing Glucagon Responses
Chen, Z., Sheng, L., Shen, H., Zhao, Y., Wang, S., Brink, R. A., & Rui, L. (2012) · Diabetes · doi:10.2337/db11-0474 · Cited by 58
Anderson, R. L., Ternes, S. B., Strand, K. A., & Rowling, M. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00218.2010 · Cited by 60
The transcriptional coregulator GRIP1 controls macrophage polarization and metabolic homeostasis
Coppo, M., Chinenov, Y. V., Sacta, M. A., & Rogatsky, I. (2016) · Nature Communications · doi:10.1038/ncomms12254 · Cited by 57
Antioxidant Effects of Biochanin A in Streptozotocin Induced Diabetic Rats
Sadri, H., Goodarzi, M. T., Salemi, Z., & Seifi, M. (2017) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2017160741 · Cited by 56
Sheikhansari, G., Soltani‐Zangbar, M. S., Pourmoghadam, Z., Kamrani, A., Azizi, R., Maleki, L. A., Danaii, S., Koushaeian, L., Hojjat‐Farsangi, M., & Yousefi, M. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13170 · Cited by 59
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 77
Bjornsson, E. S., & Angulo, P. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.09.001 · Cited by 60
Park, M., & Sung, M. (2014) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6973 · Cited by 59
Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact
Elgretli, W., Chen, T., Kronfli, N., & Sebastiani, G. (2023) · Biomedicines · doi:10.3390/biomedicines11020271 · Cited by 55
“HCV produces an unbalanced ratio of T helper (Th)1/Th2 cyto- kines, which disrupts the equilibrium between cellular immunity, promoted and main- tained by interleukin (IL)-2, TNF-α and interferon-γ, and humoral immunity, sustained by IL-4, IL-5, IL-6 and IL-10 [117].”
BackgroundInfluentialTolman, K. G., Freston, J. W., Kupfer, S., & Pérez, A. (2009) · Drug Safety · doi:10.2165/11316510-000000000-00000 · Cited by 61
Díaz-Soto, G., de Luis, D. A., Conde, R., Izaola-Jáuregui, O., Ramos, C., & Romero, E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.01.019 · Cited by 56
“These inflammatory markers have been reported in vitro and in vivo as inducers of insulin resistance [19].”
BackgroundAoi, W., Naito, Y., & Yoshikawa, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.014 · Cited by 62
Preventive Effects of Bofutsushosan on Obesity and Various Metabolic Disorders
Shimada, T., Kudo, T., Akase, T., & Aburada, M. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1362 · Cited by 55
Cytokine Abnormalities in the Etiology of the Cardiometabolic Syndrome
DeMarco, V. G., Johnson, M. S., Whaley‐Connell, A. T., & Sowers, J. R. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0095-5 · Cited by 59
“Transgenic mice lacking TNF-α or its receptor are protected from obesity-induced insulin resistance [17].”
BackgroundPI3K: An Attractive Candidate for the Central Integration of Metabolism and Reproduction
Acosta‐Martínez, M. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00110 · Cited by 59
“For example, TNF-α is a known inducer of insulin resistance, presumably through its ability to interfere with insulin receptor signaling (Feinstein et al., 1993; Uysal et al., 1997).”
BackgroundDiabetes and Suppressors of Cytokine Signaling Proteins
Rønn, S. G., Billestrup, N., & Mandrup-Poulsen, T. R. (2007) · Diabetes · doi:10.2337/db06-1068 · Cited by 59
The NLPR3 inflammasome and obesity‐related kidney disease
Ke, B., Shen, W., Fang, X., & Wu, Q. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13333 · Cited by 55
Regulation of immunometabolism in adipose tissue
Kumari, M., Heeren, J., & Scheja, L. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0668-3 · Cited by 57
The Immune Deficiency Pathway Regulates Metabolic Homeostasis in Drosophila
Davoodi, S., Galenza, A., Panteluk, A., Deshpande, R., Ferguson, M., Grewal, S., & Foley, E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801632 · Cited by 56
The adipokine/ceramide axis: Key aspects of insulin sensitization
Xia, J. Y., Morley, T. S., & Scherer, P. E. (2014) · Biochimie · doi:10.1016/j.biochi.2013.08.013 · Cited by 52
Dietary modulation of the inflammatory cascade
Dawson, D. R., Branch‐Mays, G. L., González, O. A., & Ebersole, J. L. (2013) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00458.x · Cited by 61
Obesity and airway responsiveness: Role of TNFR2
Williams, A. S., Chen, L., Kasahara, D. I., Si, H., Wurmbrand, A. P., & Shore, S. A. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.05.001 · Cited by 55
Parker, B., & Bruce, I. N. (2013) · Lupus · doi:10.1177/0961203313502570 · Cited by 61
Role of nuclear receptor corepressor RIP140 in metabolic syndrome
Rosell, M., Jones, M. C., & Parker, M. G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.016 · Cited by 56
Alokail, M. S., Al‐Daghri, N. M., Al-Attas, O. S., & Hussain, T. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-33 · Cited by 58
The Extent of Alveolar Bone Loss Is Associated With Impaired Glucose Tolerance in Japanese Men
Saito, T., Murakami, M., Shimazaki, Y., Matsumoto, S., & Yamashita, Y. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.050061 · Cited by 54
Bond, D. J., Andreazza, A. C., Hughes, J. R., Dhanoa, T., Torres, I. J., Kozicky, J.-M., Young, L. T., Lam, R. W. M., & Yatham, L. N. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.12.012 · Cited by 58
Dendritic cells and adipose tissue
Rajan, S. S., & Longhi, M. P. (2016) · Immunology · doi:10.1111/imm.12653 · Cited by 54
Priyanka, A., Sindhu, G., Shyni, G. L., Rani, M., Nisha, V. M., & Raghu, K. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.11.019 · Cited by 55
Hypothalamic Dysfunction in Obesity and Metabolic Disorders
Carmo‐Silva, S., & Cavadas, C. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-63260-5_4 · Cited by 65
Obesity and Adipose Tissue Dysfunction: From Pediatrics to Adults
Menendez, A., Wanczyk, H., Walker, J. M., Zhou, B., Santos, M., & Finck, C. M. (2022) · Genes · doi:10.3390/genes13101866 · Cited by 59
Relationship between periodontitis and hepatic condition in Japanese women.
Saito, T., Shimazaki, Y., Koga, T., Tsuzuki, M., & Ohshima, A. (2006) · PubMed · Cited by 66
Munenaga, Y., Yamashina, T., Tanaka, J., & Nishimura, F. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.01.028 · Cited by 54
“TNF-a is a well-known inflammatory cytokine as well as an adipokine, and it induces insulin resistance [10,11].”
BackgroundRoy, P. K., Islam, J., & Lalhlenmawia, H. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00352-7 · Cited by 56
“It was observed that mice lacking TNF-α or its receptor are resistant to the development of insulin resistance [108].”
BackgroundTumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
Perfield, J. W., Lee, Y., Shulman, G. I., Samuel, V. T., Jurczak, M. J., Chang, E., Xie, C., Tsichlis, P. N., Obin, M. S., & Greenberg, A. S. (2011) · Diabetes · doi:10.2337/db10-0715 · Cited by 53
Sato, N., Kaneko, M., Tamura, M., & Kurumatani, H. (2010) · Diabetes · doi:10.2337/db09-1432 · Cited by 54
“It is known that these changes may decrease insulin signaling (22-23).”
BackgroundCCR7 Maintains Nonresolving Lymph Node and Adipose Inflammation in Obesity
Hellmann, J. L., Sansbury, B. E., Holden, C. R., Tang, Y., Wong, B. C. K., Wysoczynski, M., Rodríguez, J., Bhatnagar, A., Hill, B. G., & Spite, M. R. (2016) · Diabetes · doi:10.2337/db15-1689 · Cited by 58
Role of renin–angiotensin–aldosterone system in adipose tissue dysfunction
Jing, F., Mogi, M., & Horiuchi, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.03.005 · Cited by 58
Adiponectin multimers in maternal plasma
Mazaki‐Tovi, S., Romero, R. J., Kusanovic, J. P., Erez, O., Vaisbuch, E., Gotsch, F., Mittal, P., Than, N. G., Nhan-Chang, C. L., Chaiworapongsa, T., et al. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050802266881 · Cited by 55
Chen, H., Hansen, M. J., Jones, J. E., Vlahos, R., Anderson, G. P., & Morris, M. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00442.2007 · Cited by 52
Ru, X., Yang, L., Shen, G., Wang, K., Xu, Z., Bian, W., Zhu, W., & Guo, Y. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1367395 · Cited by 58
“Knockout mouse models lackingTNF-α function show improvedinsulin sensitivityandglucose homeostasis, highlighting TNF-α ′ s role in modulating insulin action in obesity (Hotamisligil et al., 1993; Uysal et al., 1997; Ventre et al., 1997).”
BackgroundThe physiology of MASLD: molecular pathways between liver and adipose tissues
Lee, W., Kipp, Z. A., Bates, E. A., Pauss, S. N., Martinez, G. J., & Hinds, T. D. (2025) · Clinical Science · doi:10.1042/cs20257571 · Cited by 56
“Uysal et al. demonstrated that TNFα null mice (TNFα -/- ) fed a diet high in fat to induce obesity were protected against hyperinsulinemia and had a 26% decrease in serum triglyceride levels [255].”
Wang, J., Feng, Z., Li, Y., Li, Q., & Tao, X. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06978.x · Cited by 52
Meyer, M., Schwärzler, J., Jukic, A., & Tilg, H. (2024) · Biomolecules · doi:10.3390/biom14040476 · Cited by 50
“Further elegant studies revealed that mice lacking TNF function exhibited improved insulin sensitivity and had lower levels of circulating free fatty acids in diet-induced obesity models [20].”
Background
Metadata
- Authors
- Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S.
- Affiliations
- Harvard University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Hotamisligil, Gkhan S.
- Venue
- Nature
- Published
- 1997-10
- Volume
- 389
- Issue
- 6651
- Pages
- 610-614
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1764140709
- Cited by
- 2,234
- References
- 26
- Citations by year
- 2026: 15 · 2025: 39 · 2024: 40 · 2023: 48 · 2022: 50 · 2021: 77 · 2020: 79 · 2019: 79 · 2018: 80 · 2017: 96 · 2016: 71 · 2015: 111 · 2014: 106 · 2013: 141 · 2012: 122
- FWCI
- 33.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- TNF-α, insulin resistance, obesity, diet-induced obesity, ob/ob mice, free fatty acids, insulin receptor signaling, type 2 diabetes, adipose tissue, skeletal muscle
- MeSH terms
- Adipose Tissue, Animals, Fatty Acids, Glucose, Glucose Tolerance Test, Homeostasis, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Monosaccharide Transport Proteins, Muscle Proteins, Mutation, Obesity, Phosphorylation, Receptor, Insulin, Triglycerides, Tumor Necrosis Factor-alpha, Signal Transduction, Receptors, Tumor Necrosis Factor, Glucose Transporter Type 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.